A recent report has indicated that expression of ERK5 in breast tumors is linked to patient outcome, since patients with tumors with high levels of ERK5 have a poor prognosis as compared to those whose tumors do not overexpress ERK5 [9]. The gene discussed is MAPK7; the disease is breast neoplasm.